1. Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B. (9th July 2013) Authors: Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Rusen, L.; Lamas, J. L.; Oh, M.‐S.; Chapman, M.; Fritsch, S.; Pavlova, B. G.; Wong, W.‐Y.; Abbuehl, B. E. Journal: Haemophilia Issue: Volume 20:Number 1(2014:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Simultaneous determination of water‐soluble whitening ingredients and adenosine in different cosmetic formulations by high‐performance liquid chromatography coupled with photodiode array detection. (23rd December 2015) Authors: Jeon, J.‐S.; Kim, H.‐T.; Kim, M.‐G.; Oh, M.‐S.; Hong, S.‐R.; Yoon, M.‐H.; Cho, S.‐M.; Shin, H.‐C.; Shim, J.‐H.; Ramadan, A.; Abd El‐Aty, A. M. Journal: International journal of cosmetic science Issue: Volume 38:Number 3(2016) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗